Get the Stockscreener App
228.61
0.72%
1.64
Overview
News
Price History
Option Chain
Financials
Why LH Down?
Discussions
Forecast
Stock Split
Dividend History
Labcorp Holdings Inc stock is traded at $228.61, with a volume of 841.17K.
It is up +0.72% in the last 24 hours and down -3.88% over the past month.
Laboratory Corp. of America is one of the nation's two largest independent clinical laboratories, with roughly 20% of the independent lab market. The company operates approximately 2,000 patient-service centers, offering a broad range of 5,000 clinical lab tests, ranging from routine blood and urine screens to complex oncology and genomic testing.
See More
Previous Close:
$226.97
Open:
$227.85
24h Volume:
841.17K
Relative Volume:
1.50
Market Cap:
$19.12B
Revenue:
$12.71B
Net Income/Loss:
$435.50M
P/E Ratio:
30.56
EPS:
7.48
Net Cash Flow:
$843.20M
1W Performance:
-1.47%
1M Performance:
-3.88%
6M Performance:
+10.24%
1Y Performance:
+3.82%
1-Day Range:
$226.56
$229.77
1-Week Range:
$225.15
$233.97
52-Week Range:
$191.97
$247.99
Labcorp Holdings Inc Stock (LH) Company Profile
Name
Labcorp Holdings Inc
Sector
Industry
Phone
(336) 229-1127
Address
358 S MAIN ST, BURLINGTON, NC
Compare LH with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LH
Labcorp Holdings Inc
|
228.61 | 19.12B | 12.71B | 435.50M | 843.20M | 5.15 |
|
TMO
Thermo Fisher Scientific Inc
|
524.05 | 200.45B | 42.37B | 6.14B | 7.78B | 15.95 |
|
DHR
Danaher Corp
|
228.55 | 165.08B | 23.74B | 3.89B | 4.98B | 5.24 |
|
A
Agilent Technologies Inc
|
134.51 | 38.36B | 6.51B | 1.29B | 1.37B | 4.42 |
|
IQV
Iqvia Holdings Inc
|
197.27 | 35.80B | 15.32B | 1.41B | 1.96B | 7.62 |
|
IDXX
Idexx Laboratories Inc
|
412.26 | 33.76B | 3.84B | 866.24M | 792.60M | 10.37 |
Labcorp Holdings Inc Stock (LH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-10-24 | Resumed | Jefferies | Buy |
| Oct-30-24 | Upgrade | HSBC Securities | Hold → Buy |
| Oct-01-24 | Initiated | Piper Sandler | Neutral |
| Mar-25-24 | Upgrade | Argus | Hold → Buy |
| Feb-26-24 | Initiated | Leerink Partners | Outperform |
| Feb-09-24 | Initiated | Evercore ISI | In-line |
| Jan-03-24 | Initiated | Barclays | Equal Weight |
| Sep-06-23 | Initiated | HSBC Securities | Hold |
| Dec-12-22 | Downgrade | Citigroup | Buy → Neutral |
| Sep-19-22 | Downgrade | Argus | Buy → Hold |
| Aug-22-22 | Resumed | Morgan Stanley | Overweight |
| Jan-28-22 | Downgrade | Deutsche Bank | Buy → Hold |
| Jan-11-21 | Upgrade | Argus | Hold → Buy |
| Jan-11-21 | Downgrade | Wolfe Research | Peer Perform → Underperform |
| Jan-08-21 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Jul-14-20 | Upgrade | BofA Securities | Neutral → Buy |
| Jul-13-20 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Jun-02-20 | Resumed | Deutsche Bank | Buy |
| May-15-20 | Upgrade | Mizuho | Neutral → Buy |
| Apr-29-20 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Apr-27-20 | Upgrade | Citigroup | Neutral → Buy |
| Apr-27-20 | Upgrade | Wolfe Research | Underperform → Peer Perform |
| Jan-08-20 | Initiated | Wells Fargo | Overweight |
| Jul-16-19 | Upgrade | BofA/Merrill | Underperform → Neutral |
| Jun-21-19 | Upgrade | Deutsche Bank | Hold → Buy |
| Apr-02-19 | Upgrade | Jefferies | Hold → Buy |
| Jan-17-19 | Initiated | UBS | Buy |
| Jan-03-19 | Downgrade | BofA/Merrill | Neutral → Underperform |
| Dec-03-18 | Downgrade | Craig Hallum | Buy → Hold |
| Oct-30-18 | Downgrade | Argus | Buy → Hold |
| Oct-25-18 | Downgrade | Canaccord Genuity | Buy → Hold |
| Oct-19-18 | Resumed | BofA/Merrill | Buy |
| Jun-07-18 | Upgrade | KeyBanc Capital Mkts | Sector Weight → Overweight |
| May-01-18 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Mar-23-18 | Initiated | Argus | Buy |
View All
Labcorp Holdings Inc Stock (LH) Latest News
Labcorp Holdings Inc. stock rises Friday, still underperforms market - MarketWatch
Labcorp Settles Competition Suit Against Ex-Sales Exec - Law360
Labcorp Holdings Inc. stock outperforms competitors on strong trading day - MarketWatch
Labcorp Launches H5 Bird Flu Test Amid US Outbreak: Stock to Gain? - Yahoo Finance
Labcorp Declares Quarterly Dividend - Kilgore News Herald
Labcorp Holdings Inc. stock outperforms competitors despite losses on the day - MarketWatch
LH Stock May Gain From Select MAWD Pathology Asset Purchase Deal - MSN
Labcorp bird flu test takes flight - BioWorld Online
Labcorp Launches H5 Bird Flu Test in the U.S., Now Available for Order through Physicians - Marketscreener.com
Labcorp releases H5 bird flu test as outbreak spreads By Investing.com - Investing.com Canada
Labcorp Launches H5 Bird Flu Test in the U.S., Now Available for Order through Physicians – Company Announcement - Financial Times
Labcorp's SWOT analysis: new CFO, strong Q2 drive stock outlook By Investing.com - Investing.com Australia
Labcorp Agrees to Acquire Certain Legacy Health Outreach Laboratory Business Assets - Marketscreener.com
Labcorp's SWOT analysis: new CFO, strong Q2 drive stock outlook - Investing.com
Cell Free DNA (cfDNA) Testing Market Outlook to 2028 & 2033 - GlobeNewswire Inc.
Labcorp Forges Strategic Partnership with Tufts Medicine, Will A - GuruFocus.com
Labcorp closes takeover of Ballad Health outreach laboratory services - Yahoo Finance
Labcorp Holdings Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Labcorp Accuses Ex-Sales Exec Of Stealing Customers - Law360
Labcorp to Speak at the Baird 2024 Global Healthcare Conference - The Eastern Progress Online
In-Vitro Toxicology Testing Market Projected to Reach USD 30.06 Bn by 2033 - GlobeNewswire Inc.
Those who invested in Labcorp Holdings (NYSE:LH) five years ago are up 70% - Simply Wall St
Jefferies initiates Laboratory Corp with Buy, sets $275 target By Investing.com - Investing.com Canada
Labcorp Completes Acquisition of Select Assets of BioReference Health's Diagnostics Business from OPKO Health - The Eastern Progress Online
Labcorp Expands Sexually Transmitted Infection (STI) Test Offerings with Rapid Syphilis Test - The Eastern Progress Online
Labcorp Holdings Inc. stock underperforms Friday when compared to competitors - MarketWatch
Mercy BioAnalytics, Inc. announced that it expects to receive $59.999993 million in funding - Marketscreener.com
Insider Sell: Dwight Gilliland Sells 1,000 Shares of Labcorp Hol - GuruFocus.com
Labcorp director sells $241,000 in common stock - Investing.com
Labcorp executive sells $2.8 million in stock - Investing.com
Labcorp director sells $241,000 in common stock By Investing.com - Investing.com UK
Be Patient, Earn Dividends From Labcorp, The Leading Patient Clinical Lab Brand - Seeking Alpha
Labcorp to Acquire Select Assets From AtlantiCare - Marketscreener.com
Labcorp's EVP Amy Summy sells shares worth $877,141 By Investing.com - Investing.com Canada
Labcorp's EVP Amy Summy sells shares worth $877,141 - Investing.com India
Is Wall Street Bullish or Bearish on Labcorp Holdings Stock? - MSN
Outcomes4Me and Labcorp Study Reveals Digital Education Can Increase HER2-low Awareness for Metastatic Breast Cancer Patients - Yahoo Finance
Is Wall Street Bullish Or Bearish On Labcorp Holdings Stock? - Barchart
Labcorp's EVP Sandra van der Vaart sells $239,418 in stock - Investing.com India
Insider Sell: van der Vaart Sandra D Sells 1,000 Shares of Labco - GuruFocus.com
Labcorp's EVP Sandra van der Vaart sells $239,418 in stock By Investing.com - Investing.com Canada
At US$240, Is It Time To Put Labcorp Holdings Inc. (NYSE:LH) On Your Watch List? - Yahoo Finance
Ex-Dividend Reminder: Avista, Johnson & Johnson and Labcorp Holdings - Nasdaq
Three Days Left To Buy Labcorp Holdings Inc. (NYSE:LH) Before The Ex-Dividend Date - Simply Wall St
Labcorp Holdings Inc Stock (LH) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.40%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):